ReviewCancers2020

CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge.

Debora de Melo Gagliato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.